It seems we can’t find what you’re looking for. Perhaps searching can help.
Here are the positive facts about rapid lateral flow tests (LFTs) that highlight their value in healthcare, diagnostics, and disease screening:
Provide results typically in 5–15 minutes, enabling immediate clinical decisions.
No lab equipment required; can be performed by non-specialists with minimal training.
Low manufacturing and operational costs make them ideal for large-scale screening and use in resource-limited settings.
Compact, lightweight design makes LFTs ideal for point-of-care, home, and mobile clinics.
Often use blood from a finger prick, saliva, urine, or nasal swabs, improving patient comfort and compliance.
Used across multiple fields:
Infectious diseases (COVID-19, flu, HIV)
Chronic conditions (cardiac markers, kidney disease)
Cancer screening (via tumor markers like PSA, CEA, AFP)
Pregnancy and fertility (hCG, LH tests)
Environmental and food safety
Essential in rural or underserved areas without access to centralized labs.
Early detection of disease leads to better outcomes, reduced hospitalizations, and lower healthcare costs.
Can be integrated with smartphone apps or reader devices for enhanced accuracy, tracking, and remote monitoring.
Widely used and trusted globally with decades of use in diagnostics—especially in public health campaigns and pandemic response.
It seems we can’t find what you’re looking for. Perhaps searching can help.